Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarction.

Wansi ZhongShenqiang YanZhicai ChenZhongyu LuoYi ChenXuting ZhangChenglong WuWeiguo TangXiaoling ZhangYaxian WangQun GuDongjuan XuHongfang ChenMin Lounull null

Published in: Journal of neurology, neurosurgery, and psychiatry (2022)

Antiplatelet therapy can be safely used between 24 and 48 hours when HI occurs after IVT, and such therapy is associated with reduced risk of END and improved neurological outcome in patients who had an AIS.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
pulmonary embolism
atrial fibrillation
cerebral ischemia
stem cells
coronary artery disease
subarachnoid hemorrhage